Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Why aren't all shares like WEY. Buy on Tuesday and I'm up a grand by Friday.
Good to see directors buying.
According to Investors Chronicle, the Aecom announcement is delayed, But (according to an NR tweet) It's not the fault of the customer or their customer. In fact the IC article is generally pretty disparaging towards VRS.
DD, the major problem you have is indecision. I didn't want to buy Fevertree on a £3.00 spike and then again at £7.00 after that it was out of my pricerange. It's now at £31.00. The same happened with Blue Prism. At some point, you just have to trust your own research and go for it. I first bought at 220p then at 228p and topped up at 312p, so you can imagine after the last couple of days I would be panicking, but no, I shut down my pc and went out to mix some cement. At some point you have to make a decision and live by it, win or lose.
I'm slightly out of my depth here so I would have a word with HL about whether it is more cost effective for you to sell your shares and move cash over because as I remember, HL will sell all your shares and re-buy them in your new HL accounts anyway. If you will be charged an exit fee for each share you hold in your old accounts, if you no longer hold any shares they can't charge you an exit fee unless they charge a levy on moving cash. These are just my thoughts which may be rubbish, but do talk to HL first before doing anything. They are very helpful, and good luck.
It's a long time since I transferred to Hargreaves Lansdown, but I have found them to be top notch and with reasonable prices, although not the cheapest their, service is brilliant. It's up to you, but trading costs are about £11 per trade if you do it yourself. I would move cash rather than shares if I were you and even though HL doesn't charge to transfer to them, their non diy share dealing charges are quite high. Wherever you go, set up a share dealing ISA and transfer cash into it. If you prefer a trading account and you have a trusted partner (wife etc) put it in joint names because it doubles your CGT allowance. I'm pretty sure this is correct.
"Real Long Termers" Is this some kind of badge of honour? It strikes me that you just got your timing badly wrong. I invested just over a year ago and I'm over 200% up, so do I qualify for good luck or did I just get my timing right?
.....you are interested, I am heavily into VRS which has massive potential and has made terrific profits for me so far and also Avacta (AVCT) which also has huge potential when the in vivo trials start in 2020. I also missed Fevertree and Blue Prism, but hopefully just in time with RENE.
...some more today.
Yes Manifesto, I have been following Avacta since 2009 and It's only just making headway this year, but the next few years could be transformational for the company and the antibody business. I was in RENE when the sp was hyped up to 5p for a placing, but drifted back to 3p,so I got out. Looking forward to seeing where this goes. GL.
I quite agree and there's also the "too late to get in at a good price" syndrome. I made that mistake with Blue Prism and Fevertree. I bought in here at £2.20 which is very unusual for me, but I am beginning to think that it will be money well invested even though I've only bought 1500 shares.
Sounds like the bloke from Grapheneca has found one of NRs scripts and is reading it word for word. I just hope that VRS doesn't have to fight IP lawsuites.
...to extend trials of graphene enhanced road surface as it appears to have increased durability by 250%. Reported on Proactive Investors.
What caught my eye with AGM was the drop from £2.85 to 35p. A similar path to HAYD.
Signed yesterday.
I take your point, but the LG deal worth £310mil sent the sp up by 7p to around 30p where it stayed until early Jan. 7p rise for an order worth £310mil is a joke, so surely investors were put off by the lack of any payment timescale, and will be further confused by Hardman's estimated sales for 2021 of £8.6mil which aparrantly does not include much of the LG payment, which could be construed that LG aren't paying the big money until after 2021. Sales may well be £150mil by 2021, but we don't know that at this point in time.
Thanks for that cf456. Unfortunately it is understandable why the SP has not reacted to recent news. Hardman has the estimated AVCT sales forecast of £8.6mil by 2021 which is not a lot really considering that there is a deal worth $310 mil in the offing. I don't think that it matters how many deals Avacta makes, because it's all about timescales and show me the money. Without knowing when, and how much, Hardman can wake the market every day, it will make little difference to the SP. Nevertheless, looking at the like for like sales possibilities shown near the end of the report, Avacta has the potential to be a real cracker, but patience is the watchword.
Peter Jay out, Yi Luo in.
According to ADVFN, HER was 37.8% up just before suspension. Any ideas?
Is this another of my AIM dead ducks about to be cremated?